Tisagenlecleucel: neurotoxicity and cytokine release syndrome

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-51809-6
中图分类号
学科分类号
摘要
引用
收藏
页码:15 / 15
相关论文
共 50 条
  • [3] Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
    Porter, David
    Frey, Noelle
    Wood, Patricia A.
    Weng, Yanqiu
    Grupp, Stephan A.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [5] Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
    Morris, Emma C.
    Neelapu, Sattva S.
    Giavridis, Theodoros
    Sadelain, Michel
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (02) : 85 - 96
  • [6] Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
    Emma C. Morris
    Sattva S. Neelapu
    Theodoros Giavridis
    Michel Sadelain
    Nature Reviews Immunology, 2022, 22 : 85 - 96
  • [7] Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
    David Porter
    Noelle Frey
    Patricia A. Wood
    Yanqiu Weng
    Stephan A. Grupp
    Journal of Hematology & Oncology, 11
  • [8] Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial
    Schuster, Stephen J.
    Maziarz, Richard T.
    Rusch, Elisha S.
    Li, Junlong
    Signorovitch, James E.
    Romanov, Vadim V.
    Locke, Frederick L.
    Maloney, David G.
    BLOOD ADVANCES, 2020, 4 (07) : 1432 - 1439
  • [9] Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
    D. Porter
    N. Frey
    P. A. Wood
    Y. Weng
    S. A. Grupp
    Journal of Hematology & Oncology, 11